Cargando…
Zeaxanthin Dipalmitate Therapeutically Improves Hepatic Functions in an Alcoholic Fatty Liver Disease Model through Modulating MAPK Pathway
In the current study, the therapeutic effects of zeaxanthin dipalmitate (ZD) on a rat alcoholic fatty liver disease (AFLD) model were evaluated. After-treatment with ZD from the 5(th) week to the 10(th) week in a 10-week ethanol intragastric administration in rats significantly alleviated the typica...
Autores principales: | Xiao, Jia, Wang, Jiteng, Xing, Feiyue, Han, Tao, Jiao, Rui, Liong, Emily C., Fung, Man-Lung, So, Kwok-Fai, Tipoe, George L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3989301/ https://www.ncbi.nlm.nih.gov/pubmed/24740309 http://dx.doi.org/10.1371/journal.pone.0095214 |
Ejemplares similares
-
Zeaxanthin Dipalmitate in the Treatment of Liver Disease
por: Bahaji Azami, Nisma Lena, et al.
Publicado: (2019) -
Lycium barbarum polysaccharides therapeutically improve hepatic functions in non-alcoholic steatohepatitis rats and cellular steatosis model
por: Xiao, Jia, et al.
Publicado: (2014) -
Recent Advances in the Herbal Treatment of Non-Alcoholic Fatty Liver Disease
por: Xiao, Jia, et al.
Publicado: (2013) -
Supercritical Fluid CO(2) Extraction and Microcapsule Preparation of Lycium barbarum Residue Oil Rich in Zeaxanthin Dipalmitate
por: Men, Yan, et al.
Publicado: (2021) -
Garlic-derived S-allylmercaptocysteine is a hepato-protective agent in non-alcoholic fatty liver disease in vivo animal model
por: Xiao, Jia, et al.
Publicado: (2012)